Pharmaceutical companies don't have nearly the access to doctors that they once enjoyed.
ZS, a global sales and marketing firm, analyzed call reports from 70 percent of pharmaceutical sales reps and found that for the first time since it began conducting such reports, more than half of physicians were classified as restricted to a certain extent from engaging with pharma reps.
The decline in access has been dramatic over the past five years. While nearly 80 percent of doctors were considered accessible in the first quarter of 2009, only 47 percent are unrestricted today. The effect has been even more significant in certain areas of medicine. While 75 percent of oncologists were labeled "accessible" in 2010, 73 percent are now considered "access-restricted."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
